Haemonetics Corporation (HAE) support and resistance · P/E 35, rev $1.36B
Haemonetics Corporation (HAE) is a medical devices company listed on US.
This page maps Haemonetics Corporation (HAE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
HAE currently screens at market cap $3.24B and trailing P/E 34.8. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new HAE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the HAE quote page for the session range and the stock page for the full model.
Not investment advice.